The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells

The human telomerase reverse transcriptase (hTERT) promoter can be used for the tumor-specific expression of transgenes in order to induce selective cancer cell death. The hTERT core promoter is active in cancer cells but not in normal cells. To examine whether the combination of TNF-related apoptos...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Eunah, Kim, Youngtae, Kim, Kunhong
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2006
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687581/
https://www.ncbi.nlm.nih.gov/pubmed/16502485
http://dx.doi.org/10.3349/ymj.2006.47.1.55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687581/
https://www.ncbi.nlm.nih.gov/pubmed/16502485
http://dx.doi.org/10.3349/ymj.2006.47.1.55

Ejemplares similares